What is it about?
At present, every nation is focused on meeting sustainable development goals (SDGs) by 2030 for social, economic, and environmental sustainability. Automation of drug discovery, reliable research and innovation, green chemistry, and a lean discovery process are all critical components, where sustainability implementation is applicable. The current pandemic crisis has contributed to making society more familiar with the significance of advancements in this area. According to prior studies, the adoption of Industry 4.0 enabling technologies could contribute to sustainability across all areas. It is also observed that there are limited studies that discuss industry 4.0 enabling technologies implementation for drug discovery in the progress of attaining sustainability.
Featured Image
Why is it important?
Industry 4.0 refers to the integration of advanced digital technologies like artificial intelligence (AI), machine learning (ML), big data analytics, robotics, the Internet of Things (IoT), and automation into traditional manufacturing and development processes. In the pharmaceutical industry, adopting these technologies can revolutionize how drugs are discovered, developed, tested, and brought to market. The adoption of Industry 4.0 technologies can significantly enhance the efficiency and speed of drug discovery. AI and ML can analyze vast amounts of biological and chemical data to identify potential drug candidates faster than traditional methods.
Perspectives
The review would likely examine how specific Industry 4.0 technologies—such as artificial intelligence (AI), machine learning (ML), big data analytics, robotics, blockchain, and IoT—are being applied in drug discovery and development. This perspective would explore how these technologies drive innovation, automate repetitive tasks, improve accuracy, and enable new approaches to drug discovery (e.g., AI-driven drug design, virtual screening). The review could highlight how Industry 4.0 technologies improve operational efficiencies, reduce costs, and accelerate timelines in drug development processes.
Vaseem Akram Shaik
Read the Original
This page is a summary of: Industry 4.0 technologies adoption for digital transition in drug discovery and development: A review, Journal of Industrial Information Integration, March 2024, Elsevier,
DOI: 10.1016/j.jii.2024.100562.
You can read the full text:
Contributors
The following have contributed to this page
